PD-1 Monoclonal Antibody Combined With FLOT Regimen for Neoadjuvant Therapy of Gastric Adenocarcinoma
Clinical trial NCT04341857 · UNKNOWN
Trial details
- NCT number
- NCT04341857
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-30
- Primary completion
- 2022-05-30
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.